Medical Device News Magazine

Sparrow BioAcoustics Announces the Launch of Stethophone™ – Bringing the Future of Personalized Heart Care Closer to Home

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Stethophone™ by Sparrow BioAcoustics

Sparrow BioAcoustics [Sparrow], a pioneer in the field of bioacoustics technology, announces the launch of Stethophone™, a groundbreaking advancement in personalized heart health, exclusively on Valentine’s Day, February 14, 2024. This innovative software turns smartphones into medical-grade stethoscopes, allowing people to capture, analyze, and share critical heart health data with medical personnel from the comfort of any location.

Built-in Microphone

Stethophone works by harnessing the built-in microphone of a smartphone to capture the nuanced sounds of the heart. Through sophisticated bioacoustics engineering, these sounds are then filtered to provide clear, medical-grade diagnostic signals – some of them at the outermost edges of human auditory perception. With widespread adoption, it is anticipated that this bioacoustics technology will allow for the detection and diagnosis of routine and difficult cardiac conditions sooner and with more ease.

FDA Clearance

An an unprecedented move, Stethophone recently won FDA clearance in 2023 for use by medical professionals in the United States, marking it as the first-ever FDA-cleared smartphone stethoscope Software-as-a-Medical-Device (SaMD). Furthermore, the software has achieved another landmark by obtaining FDA clearance, again in 2023, for use by consumers – another first in the industry – empowering individuals to take an active role in their heart health.

In addition to providing the sophisticated bioacoustics technology that powers Stethophone, Sparrow offers medical practitioners advanced visualizations that enable them to understand how to interpret the diagnostics originating from the device. These visualizations aid in the recognition of patterns and anomalies that may not be easily discernible by conventional cardiac diagnostics, thereby potentially enhancing today’s diagnostic accuracy and efficiency.

Mark Attila Opauzsky, CEO of Sparrow BioAcoustics

“We are at the forefront of a revolution in personalized heart health. Stethophone embodies our commitment to provide everyone the power, agency and access to fight heart disease right in their own hands. Launching on Valentine’s Day symbolizes our dedication to heart health and the love and care we invest in our products and the people they serve.” Valentine’s Day also marks the five-year anniversary when Mark almost lost his life to a sudden, rare disease. To him, this launch is very personal.

Future

As Sparrow eagerly celebrates the release of Stethophone, the company is already looking toward the future with the development of the next iteration of Stethophone, which explores integrating artificial intelligence functionalities into the bioacoustics engineering.

Stethophone is available now on iOS. To learn more about Stethophone and Sparrow BioAcoustics, please visit https://stethophone.com/.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”